Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514356 | SCV000609526 | likely benign | not provided | 2017-08-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001081811 | SCV000653736 | benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514356 | SCV001780374 | uncertain significance | not provided | 2022-05-02 | criteria provided, single submitter | clinical testing | Reported previously in an individual in published literature who did not have a personal or family history of a CACNA1S-related disorder (Gonsalves et al., 2013); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24195946) |
Color Diagnostics, |
RCV003517213 | SCV004360404 | likely benign | Malignant hyperthermia, susceptibility to, 5 | 2022-09-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003935341 | SCV004753899 | likely benign | CACNA1S-related disorder | 2023-03-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |